Dermatology News and Research

Latest Dermatology News and Research

Actavis signs agreement with Zhejiang Chiral to acquire Actavis Foshan, China

Actavis plc today announced that it has signed and completed an agreement for Zhejiang Chiral Medicine Chemicals Co., Ltd to acquire Actavis' interest in Actavis (Foshan) Pharmaceuticals Co., Ltd., an Actavis subsidiary based in Foshan, China.

25 Jan 2014

Home blood pressure best guide to metabolic risk

Home blood pressure is a good guide to which patients are likely to have the metabolic syndrome, say researchers.

20 Jan 2014

Clinical rule stratifies CAP patients’ cardiac risk

Researchers have generated and validated a clinical rule that accurately stratifies patients hospitalized for community acquired pneumonia according to their risk for cardiac complications.

20 Jan 2014

Gouty tophi predict cardiovascular remodeling

Research shows that the severity of gout, rather than uric acid level, is significantly associated with changes in left ventricular diastolic function and left atrial volume.

16 Jan 2014

RoundTable Healthcare Partners sells Aqua Pharmaceuticals Holdings for $402.6M to Almirall

RoundTable Healthcare Partners, an operating-oriented private equity firm focused exclusively on the healthcare industry, announced today that it has completed the sale of Aqua Pharmaceuticals Holdings, Inc. to Almirall S.A. for up to $402.6 million in cash

16 Jan 2014

Obesity interferes with blood pressure control

Patients who are overweight or obese have a high risk for uncontrolled blood pressure, despite often taking multiple antihypertensive agents, say researchers.

13 Jan 2014

Cardiovascular conditions may be overlooked in bipolar disorder

Cardiovascular comorbidities may be going under-recognized and undertreated in patients with bipolar disorder, say UK researchers.

10 Jan 2014

NPF, CORRONA to create first psoriasis registry to improve treatments and patient outcomes

To advance understanding of psoriasis—the most common autoimmune disease in the country, affecting up to 7.5 million Americans—and help scientists and clinicians improve treatments and patient outcomes, the National Psoriasis Foundation and the Consortium of Rheumatology Researchers of North America, Inc. will create the first psoriasis registry co-developed and co-administered by a nonprofit.

10 Jan 2014

Auxilium Pharmaceuticals reports interim data from XIAFLEX Phase 4 study in patients with DC

Auxilium Pharmaceuticals, Inc., a fully integrated specialty biopharmaceutical company, today announced that interim data from its Phase 4 retreatment study (AUX-CC-862) evaluating XIAFLEX (collagenase clostridium histolyticum or CCH) in adult patients with Dupuytren's contracture and a recurrent contracture with a palpable cord will be presented for the first time at the American Association for Hand Surgery 2014 Annual Meeting being held January 8-11, 2014 in Kauai, Hawaii.

9 Jan 2014

FDA approves Actavis' ANDA for Telmisartan Immediate-Release Tablets

Actavis plc today announced that it has received approval from the U.S. Food and Drug Administration on its Abbreviated New Drug Application for Telmisartan Immediate-Release Tablets, 20 mg, 40 mg and 80 mg, a generic equivalent to Boehringer Ingelheim's Micardis. Actavis intends to launch the product immediately.

9 Jan 2014

Research highlights potential of newly developed radiopharmaceuticals for imaging melanoma metastases

With low survival rates for patients with metastasized melanoma, accurate staging and effective treatments are critical to extending life. New research published in the Journal of Nuclear Medicine highlights the potential of newly developed radiopharmaceuticals with benzamide for the imaging of metastases and as a targeted systemic therapy.

8 Jan 2014

Tight blood pressure control urged in patients with cardiovascular disease

Intensive antihypertensive treatment to a systolic blood pressure target of 130 mmHg is equally beneficial for patients with and without established cardiovascular disease, research suggests.

6 Jan 2014

Scientists conduct clinical trial to determine silk clothing for treatment of eczema

Three hundred children are being recruited for a clinical trial to establish whether or not specialist silk clothing really does help in the treatment of eczema.

6 Jan 2014

Chief Financial Officer of Modernizing Medicine selected as finalist for South Florida CFO Awards

Modernizing Medicine, Inc. announced today that the South Florida Business Journal selected its Chief Financial Officer Karen O'Byrne as a finalist in this year's CFO Awards.

3 Jan 2014

Apple Valley Medical Clinic Sleep Center moves to 14843 Energy Way in Apple Valley

The Apple Valley Medical Clinic's Sleep Center has moved to 14843 Energy Way in Apple Valley. The center, which opened in 2010 under the medical direction of Scott Benson, M.D., a family medicine physician with the Apple Valley Medical Clinic, offers preventive care, diagnosis and referral for treatment of sleep disorders.

3 Jan 2014

Scientists find inhibiting action of BRD4 protein may eradicate rare type of soft-tissue cancer

A deadly, rare type of soft-tissue cancer may be completely eradicated simply by inhibiting a key protein involved in its growth, UT Southwestern Medical Center researchers report.

27 Dec 2013

Actavis' subsidiary files ANDA for generic version of NuvaRing

Actavis plc today confirmed that its subsidiary, Warner Chilcott Company LLC, has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Ethinyl Estradiol and Etonogestrel Vaginal Ring, 0.015 mg/24 hour and 0.12 mg/24 hour.

26 Dec 2013

Actavis' subsidiary receives FDA complete response letter for progestin-only patch NDA

Actavis plc today confirmed that the Company's subsidiary has received a complete response letter from the U.S. Food and Drug Administration for its New Drug Application for a progestin-only transdermal contraceptive patch (Norethindrone Transdermal Delivery System) for use by women to prevent pregnancy.

24 Dec 2013

Research review examines effectiveness of treatments for chronic skin wounds

A systematic review of 66 research papers focused on the treatment of skin ulcers suggests that most are so technically flawed that their results are unreliable. And even of those that pass muster, there is only weak evidence that some treatments work better than standard compression therapy or special stockings.

24 Dec 2013

Blaze Bioscience to initiate first Phase 1 clinical study of BLZ-100 in patients with skin tumors

Blaze Bioscience, Inc. and its subsidiary, Blaze Bioscience Australia Pty Ltd, today announced the initiation of the first Phase 1 clinical study of the first Tumor Paint product candidate, BLZ-100. The study, titled "A Phase I Dose Escalation/Expansion Study of BLZ-100 Administered by Intravenous Injection in Adult Subjects with Skin Cancer," will enroll up to 30 patients with basal cell carcinoma, squamous cell carcinoma, or amelanotic melanoma.

19 Dec 2013

Dermatology News and Research

Latest Dermatology News and Research

Actavis signs agreement with Zhejiang Chiral to acquire Actavis Foshan, China

Home blood pressure best guide to metabolic risk

Clinical rule stratifies CAP patients’ cardiac risk

Gouty tophi predict cardiovascular remodeling

RoundTable Healthcare Partners sells Aqua Pharmaceuticals Holdings for $402.6M to Almirall

Obesity interferes with blood pressure control

Cardiovascular conditions may be overlooked in bipolar disorder

NPF, CORRONA to create first psoriasis registry to improve treatments and patient outcomes

Auxilium Pharmaceuticals reports interim data from XIAFLEX Phase 4 study in patients with DC

FDA approves Actavis' ANDA for Telmisartan Immediate-Release Tablets

Research highlights potential of newly developed radiopharmaceuticals for imaging melanoma metastases

Tight blood pressure control urged in patients with cardiovascular disease

Scientists conduct clinical trial to determine silk clothing for treatment of eczema

Chief Financial Officer of Modernizing Medicine selected as finalist for South Florida CFO Awards

Apple Valley Medical Clinic Sleep Center moves to 14843 Energy Way in Apple Valley

Scientists find inhibiting action of BRD4 protein may eradicate rare type of soft-tissue cancer

Actavis' subsidiary files ANDA for generic version of NuvaRing

Actavis' subsidiary receives FDA complete response letter for progestin-only patch NDA

Research review examines effectiveness of treatments for chronic skin wounds

Blaze Bioscience to initiate first Phase 1 clinical study of BLZ-100 in patients with skin tumors

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Dermatology News and Research

Latest Dermatology News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in